rs775651175
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001413023.1(RECQL4):c.-561C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,610,584 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001413023.1 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152224Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000247 AC: 6AN: 242568Hom.: 0 AF XY: 0.0000226 AC XY: 3AN XY: 132452
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1458360Hom.: 0 Cov.: 35 AF XY: 0.0000165 AC XY: 12AN XY: 725354
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152224Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74362
ClinVar
Submissions by phenotype
not provided Uncertain:1
- -
RECQL4-related disorder Uncertain:1
The RECQL4 c.511C>T variant is predicted to result in the amino acid substitution p.Arg171Trp. This variant has been reported in an individual with breast cancer and was also observed in this individual's unaffected family members (S2 Table, Kim et al. 2017. PubMed ID: 28076423). This variant is reported in 0.0058% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/8-145741992-G-A) and is interpreted as uncertain significance in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/407019/?new_evidence=false). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Baller-Gerold syndrome Uncertain:1
This sequence change replaces arginine with tryptophan at codon 171 of the RECQL4 protein (p.Arg171Trp). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs775651175, gnomAD 0.006%). This missense change has been observed in individual(s) with breast cancer (PMID: 28076423). ClinVar contains an entry for this variant (Variation ID: 407019). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RECQL4 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at